메뉴 건너뛰기
Journal of Clinical Oncology
Volumn 16, Issue 4, 1998, Pages 1298-1301
Neoadjuvant chemotherapy and bladder-sparing surgery for invasive bladder cancer: Ten-year outcome
Author keywords

[No Author keywords available]
Indexed keywords

CISPLATIN; DOXORUBICIN; METHOTREXATE; VINBLASTINE;
EID: 0031925301     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1998.16.4.1298     Document Type: Article
Times cited : (172)
References (15)
  • 1
    • 0027438095 scopus 로고
    • Selective bladder preservation by combination treatment of invasive bladder cancer
    • Kaufman DS, Shipley WU, Griffin PP, et al: Selective bladder preservation by combination treatment of invasive bladder cancer. New Eng J Med 329:1377-1382, 1993
    • (1993) New Eng J Med , vol.329 , pp. 1377-1382
    • Kaufman, D.S.1    Shipley, W.U.2    Griffin, P.P.3
  • 2
    • 0028209409 scopus 로고
    • Neoadjuvant chemotherapy and partial cystectomy for invasive bladder cancer
    • Herr HW, Scher HI: Neoadjuvant chemotherapy and partial cystectomy for invasive bladder cancer. J Clin Oncol 12:975-980, 1994
    • (1994) J Clin Oncol , vol.12 , pp. 975-980
    • Herr, H.W.1    Scher, H.I.2
  • 3
    • 0031059139 scopus 로고    scopus 로고
    • Bladder preservation by combined modality therapy for invasive bladder cancer
    • Kachnic LA, Kaufman DS, Heney NM, et al: Bladder preservation by combined modality therapy for invasive bladder cancer. J Clin Oncol 15:1022-1029, 1997
    • (1997) J Clin Oncol , vol.15 , pp. 1022-1029
    • Kachnic, L.A.1    Kaufman, D.S.2    Heney, N.M.3
  • 4
    • 0025104598 scopus 로고
    • Surgery of invasive bladder cancer: Is pathologic staging necessary?
    • Herr HW, Scher HI: Surgery of invasive bladder cancer: Is pathologic staging necessary? Semin Oncol 17:590-597, 1990
    • (1990) Semin Oncol , vol.17 , pp. 590-597
    • Herr, H.W.1    Scher, H.I.2
  • 5
    • 0028363007 scopus 로고
    • Neoadjuvant chemotherapy for invasive bladder cancer: Prognostic factors for survival of patients treated with MVAC with 5-year follow-up
    • Schultz PK, Herr HW, Zhang Z-F, et al: Neoadjuvant chemotherapy for invasive bladder cancer: Prognostic factors for survival of patients treated with MVAC with 5-year follow-up. J Clin Oncol 12:1394-1401, 1994
    • (1994) J Clin Oncol , vol.12 , pp. 1394-1401
    • Schultz, P.K.1    Herr, H.W.2    Zhang, Z.-F.3
  • 6
    • 0023860019 scopus 로고
    • Neoadjuvant MVAC (methotrexate, vinblastine, doxorubicin and cisplatin) effect on the primary bladder cancer
    • Scher HI, Yagoda A, Herr HW, et al: Neoadjuvant MVAC (methotrexate, vinblastine, doxorubicin and cisplatin) effect on the primary bladder cancer. J Urol 139:470-474, 1988
    • (1988) J Urol , vol.139 , pp. 470-474
    • Scher, H.I.1    Yagoda, A.2    Herr, H.W.3
  • 7
    • 0024215990 scopus 로고
    • Combination transurethral resection and systemic chemotherapy as primary treatment of infiltrating bladder cancer
    • Amiel J, Quintens H, Thyss A, et al: Combination transurethral resection and systemic chemotherapy as primary treatment of infiltrating bladder cancer. J Urol 94:333-336, 1988
    • (1988) J Urol , vol.94 , pp. 333-336
    • Amiel, J.1    Quintens, H.2    Thyss, A.3
  • 8
    • 0004984313 scopus 로고
    • Extended experience with neoadjuvant (MVAC) chemotherapy for invasive transitional cell carcinoma of the urinary bladder
    • abstr
    • Keating J, Zincke H, Morgan WR, et al: Extended experience with neoadjuvant (MVAC) chemotherapy for invasive transitional cell carcinoma of the urinary bladder. J Urol 141:244A, 1989 (abstr)
    • (1989) J Urol , vol.141
    • Keating, J.1    Zincke, H.2    Morgan, W.R.3
  • 10
    • 0026671572 scopus 로고
    • Transurethral resection for transitional cell carcinoma
    • Hall RR: Transurethral resection for transitional cell carcinoma. Prob Urol 6:460-470, 1992
    • (1992) Prob Urol , vol.6 , pp. 460-470
    • Hall, R.R.1
  • 11
    • 0344484451 scopus 로고
    • Neoadjuvant and adjuvant chemotherapy in locally advanced disease: What are the effects on survival and prognosis?
    • Sternberg CN, Raghaven D, Ohi Y, et al: Neoadjuvant and adjuvant chemotherapy in locally advanced disease: What are the effects on survival and prognosis? Int J Urol 2:75-87, 1995
    • (1995) Int J Urol , vol.2 , pp. 75-87
    • Sternberg, C.N.1    Raghaven, D.2    Ohi, Y.3
  • 12
    • 0028144582 scopus 로고
    • Primary MVAC chemotherapy and bladder preservation in locally invasive bladder cancer: A 5-year follow-up
    • Srougi M, Simon SD: Primary MVAC chemotherapy and bladder preservation in locally invasive bladder cancer: A 5-year follow-up. J Urol 151:593-597, 1994
    • (1994) J Urol , vol.151 , pp. 593-597
    • Srougi, M.1    Simon, S.D.2
  • 13
    • 58149362196 scopus 로고
    • Neoadjuvant MVAC and bladder preservation for muscle invasive transitional cell carcinoma of the bladder
    • Sternberg CN, Pansadora V, Lauretti S, et al: Neoadjuvant MVAC and bladder preservation for muscle invasive transitional cell carcinoma of the bladder. Urol Oncol 1:127-133, 1995
    • (1995) Urol Oncol , vol.1 , pp. 127-133
    • Sternberg, C.N.1    Pansadora, V.2    Lauretti, S.3
  • 14
    • 0025185648 scopus 로고
    • Restaging procedures, criteria of response, and relationship between pathological response and survival
    • Splinter T, Denis L: Restaging procedures, criteria of response, and relationship between pathological response and survival. Semin Oncol 17:606-612, 1990
    • (1990) Semin Oncol , vol.17 , pp. 606-612
    • Splinter, T.1    Denis, L.2
  • 15
    • 0027452436 scopus 로고
    • Combined radiation and chemotherapy for invasive transitional-cell carcinoma of the bladder: A prospective study
    • Housset M, Maulard C, Chretien Y, et al: Combined radiation and chemotherapy for invasive transitional-cell carcinoma of the bladder: A prospective study. J Clin Oncol 11:2150-2157, 1993
    • (1993) J Clin Oncol , vol.11 , pp. 2150-2157
    • Housset, M.1    Maulard, C.2    Chretien, Y.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.